Supplementary Figure 2 from PARP1 Trapping by PARP Inhibitors Drives Cytotoxicity in Both Cancer Cells and Healthy Bone Marrow Article Swipe
Todd A. Hopkins
,
William B. Ainsworth
,
Peter Ellis
,
Cherrie K. Donawho
,
Enrico L. DiGiammarino
,
Sanjay C. Panchal
,
Vivek C. Abraham
,
Mikkel A. Algire
,
Yan Shi
,
Amanda M. Olson
,
Eric F. Johnson
,
Julie L. Wilsbacher
,
David Maag
·
YOU?
·
· 2023
· Open Access
·
· DOI: https://doi.org/10.1158/1541-7786.22514782
YOU?
·
· 2023
· Open Access
·
· DOI: https://doi.org/10.1158/1541-7786.22514782
Association of PARP1 and other histone proteins detected by Proximity Ligation Assay (PLA).
Related Topics
Concepts
PARP1
Cytotoxicity
Poly ADP ribose polymerase
Bone marrow
Cancer research
Histone
Molecular biology
Chemistry
Medicine
Biology
Immunology
Biochemistry
DNA
Polymerase
In vitro
Metadata
- Type
- preprint
- Language
- en
- Landing Page
- https://doi.org/10.1158/1541-7786.22514782
- https://aacr.figshare.com/articles/journal_contribution/Supplementary_Figure_2_from_PARP1_Trapping_by_PARP_Inhibitors_Drives_Cytotoxicity_in_Both_Cancer_Cells_and_Healthy_Bone_Marrow/22514782/1/files/39977281.pdf
- OA Status
- gold
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4362529485
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4362529485Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1158/1541-7786.22514782Digital Object Identifier
- Title
-
Supplementary Figure 2 from PARP1 Trapping by PARP Inhibitors Drives Cytotoxicity in Both Cancer Cells and Healthy Bone MarrowWork title
- Type
-
preprintOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2023Year of publication
- Publication date
-
2023-04-03Full publication date if available
- Authors
-
Todd A. Hopkins, William B. Ainsworth, Peter Ellis, Cherrie K. Donawho, Enrico L. DiGiammarino, Sanjay C. Panchal, Vivek C. Abraham, Mikkel A. Algire, Yan Shi, Amanda M. Olson, Eric F. Johnson, Julie L. Wilsbacher, David MaagList of authors in order
- Landing page
-
https://doi.org/10.1158/1541-7786.22514782Publisher landing page
- PDF URL
-
https://aacr.figshare.com/articles/journal_contribution/Supplementary_Figure_2_from_PARP1_Trapping_by_PARP_Inhibitors_Drives_Cytotoxicity_in_Both_Cancer_Cells_and_Healthy_Bone_Marrow/22514782/1/files/39977281.pdfDirect link to full text PDF
- Open access
-
YesWhether a free full text is available
- OA status
-
goldOpen access status per OpenAlex
- OA URL
-
https://aacr.figshare.com/articles/journal_contribution/Supplementary_Figure_2_from_PARP1_Trapping_by_PARP_Inhibitors_Drives_Cytotoxicity_in_Both_Cancer_Cells_and_Healthy_Bone_Marrow/22514782/1/files/39977281.pdfDirect OA link when available
- Concepts
-
PARP1, Cytotoxicity, Poly ADP ribose polymerase, Bone marrow, Cancer research, Histone, Molecular biology, Chemistry, Medicine, Biology, Immunology, Biochemistry, DNA, Polymerase, In vitroTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
0Total citation count in OpenAlex
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4362529485 |
|---|---|
| doi | https://doi.org/10.1158/1541-7786.22514782 |
| ids.doi | https://doi.org/10.1158/1541-7786.22514782 |
| ids.openalex | https://openalex.org/W4362529485 |
| fwci | |
| type | preprint |
| title | Supplementary Figure 2 from PARP1 Trapping by PARP Inhibitors Drives Cytotoxicity in Both Cancer Cells and Healthy Bone Marrow |
| biblio.issue | |
| biblio.volume | |
| biblio.last_page | |
| biblio.first_page | |
| topics[0].id | https://openalex.org/T11914 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 0.9969000220298767 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2730 |
| topics[0].subfield.display_name | Oncology |
| topics[0].display_name | PARP inhibition in cancer therapy |
| is_xpac | False |
| apc_list | |
| apc_paid | |
| concepts[0].id | https://openalex.org/C2778480876 |
| concepts[0].level | 5 |
| concepts[0].score | 0.8215134143829346 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q21112674 |
| concepts[0].display_name | PARP1 |
| concepts[1].id | https://openalex.org/C109316439 |
| concepts[1].level | 3 |
| concepts[1].score | 0.6754759550094604 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q246181 |
| concepts[1].display_name | Cytotoxicity |
| concepts[2].id | https://openalex.org/C182979987 |
| concepts[2].level | 4 |
| concepts[2].score | 0.6389012336730957 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q3907241 |
| concepts[2].display_name | Poly ADP ribose polymerase |
| concepts[3].id | https://openalex.org/C2780007613 |
| concepts[3].level | 2 |
| concepts[3].score | 0.5681013464927673 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q546523 |
| concepts[3].display_name | Bone marrow |
| concepts[4].id | https://openalex.org/C502942594 |
| concepts[4].level | 1 |
| concepts[4].score | 0.5410259366035461 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q3421914 |
| concepts[4].display_name | Cancer research |
| concepts[5].id | https://openalex.org/C64927066 |
| concepts[5].level | 3 |
| concepts[5].score | 0.4757627844810486 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q36293 |
| concepts[5].display_name | Histone |
| concepts[6].id | https://openalex.org/C153911025 |
| concepts[6].level | 1 |
| concepts[6].score | 0.4458787143230438 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q7202 |
| concepts[6].display_name | Molecular biology |
| concepts[7].id | https://openalex.org/C185592680 |
| concepts[7].level | 0 |
| concepts[7].score | 0.42660990357398987 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q2329 |
| concepts[7].display_name | Chemistry |
| concepts[8].id | https://openalex.org/C71924100 |
| concepts[8].level | 0 |
| concepts[8].score | 0.35702309012413025 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[8].display_name | Medicine |
| concepts[9].id | https://openalex.org/C86803240 |
| concepts[9].level | 0 |
| concepts[9].score | 0.3121330738067627 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q420 |
| concepts[9].display_name | Biology |
| concepts[10].id | https://openalex.org/C203014093 |
| concepts[10].level | 1 |
| concepts[10].score | 0.24481233954429626 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q101929 |
| concepts[10].display_name | Immunology |
| concepts[11].id | https://openalex.org/C55493867 |
| concepts[11].level | 1 |
| concepts[11].score | 0.1872066855430603 |
| concepts[11].wikidata | https://www.wikidata.org/wiki/Q7094 |
| concepts[11].display_name | Biochemistry |
| concepts[12].id | https://openalex.org/C552990157 |
| concepts[12].level | 2 |
| concepts[12].score | 0.10916128754615784 |
| concepts[12].wikidata | https://www.wikidata.org/wiki/Q7430 |
| concepts[12].display_name | DNA |
| concepts[13].id | https://openalex.org/C82381507 |
| concepts[13].level | 3 |
| concepts[13].score | 0.08556059002876282 |
| concepts[13].wikidata | https://www.wikidata.org/wiki/Q416878 |
| concepts[13].display_name | Polymerase |
| concepts[14].id | https://openalex.org/C202751555 |
| concepts[14].level | 2 |
| concepts[14].score | 0.06791940331459045 |
| concepts[14].wikidata | https://www.wikidata.org/wiki/Q221681 |
| concepts[14].display_name | In vitro |
| keywords[0].id | https://openalex.org/keywords/parp1 |
| keywords[0].score | 0.8215134143829346 |
| keywords[0].display_name | PARP1 |
| keywords[1].id | https://openalex.org/keywords/cytotoxicity |
| keywords[1].score | 0.6754759550094604 |
| keywords[1].display_name | Cytotoxicity |
| keywords[2].id | https://openalex.org/keywords/poly-adp-ribose-polymerase |
| keywords[2].score | 0.6389012336730957 |
| keywords[2].display_name | Poly ADP ribose polymerase |
| keywords[3].id | https://openalex.org/keywords/bone-marrow |
| keywords[3].score | 0.5681013464927673 |
| keywords[3].display_name | Bone marrow |
| keywords[4].id | https://openalex.org/keywords/cancer-research |
| keywords[4].score | 0.5410259366035461 |
| keywords[4].display_name | Cancer research |
| keywords[5].id | https://openalex.org/keywords/histone |
| keywords[5].score | 0.4757627844810486 |
| keywords[5].display_name | Histone |
| keywords[6].id | https://openalex.org/keywords/molecular-biology |
| keywords[6].score | 0.4458787143230438 |
| keywords[6].display_name | Molecular biology |
| keywords[7].id | https://openalex.org/keywords/chemistry |
| keywords[7].score | 0.42660990357398987 |
| keywords[7].display_name | Chemistry |
| keywords[8].id | https://openalex.org/keywords/medicine |
| keywords[8].score | 0.35702309012413025 |
| keywords[8].display_name | Medicine |
| keywords[9].id | https://openalex.org/keywords/biology |
| keywords[9].score | 0.3121330738067627 |
| keywords[9].display_name | Biology |
| keywords[10].id | https://openalex.org/keywords/immunology |
| keywords[10].score | 0.24481233954429626 |
| keywords[10].display_name | Immunology |
| keywords[11].id | https://openalex.org/keywords/biochemistry |
| keywords[11].score | 0.1872066855430603 |
| keywords[11].display_name | Biochemistry |
| keywords[12].id | https://openalex.org/keywords/dna |
| keywords[12].score | 0.10916128754615784 |
| keywords[12].display_name | DNA |
| keywords[13].id | https://openalex.org/keywords/polymerase |
| keywords[13].score | 0.08556059002876282 |
| keywords[13].display_name | Polymerase |
| keywords[14].id | https://openalex.org/keywords/in-vitro |
| keywords[14].score | 0.06791940331459045 |
| keywords[14].display_name | In vitro |
| language | en |
| locations[0].id | doi:10.1158/1541-7786.22514782 |
| locations[0].is_oa | True |
| locations[0].source | |
| locations[0].license | cc-by |
| locations[0].pdf_url | https://aacr.figshare.com/articles/journal_contribution/Supplementary_Figure_2_from_PARP1_Trapping_by_PARP_Inhibitors_Drives_Cytotoxicity_in_Both_Cancer_Cells_and_Healthy_Bone_Marrow/22514782/1/files/39977281.pdf |
| locations[0].version | acceptedVersion |
| locations[0].raw_type | posted-content |
| locations[0].license_id | https://openalex.org/licenses/cc-by |
| locations[0].is_accepted | True |
| locations[0].is_published | False |
| locations[0].raw_source_name | |
| locations[0].landing_page_url | https://doi.org/10.1158/1541-7786.22514782 |
| indexed_in | crossref |
| authorships[0].author.id | https://openalex.org/A5041300209 |
| authorships[0].author.orcid | https://orcid.org/0000-0001-9943-6047 |
| authorships[0].author.display_name | Todd A. Hopkins |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Todd A. Hopkins |
| authorships[0].is_corresponding | False |
| authorships[1].author.id | https://openalex.org/A5043691247 |
| authorships[1].author.orcid | |
| authorships[1].author.display_name | William B. Ainsworth |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | William B. Ainsworth |
| authorships[1].is_corresponding | False |
| authorships[2].author.id | https://openalex.org/A5057361837 |
| authorships[2].author.orcid | https://orcid.org/0000-0003-1590-2130 |
| authorships[2].author.display_name | Peter Ellis |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Paul A. Ellis |
| authorships[2].is_corresponding | False |
| authorships[3].author.id | https://openalex.org/A5001511809 |
| authorships[3].author.orcid | |
| authorships[3].author.display_name | Cherrie K. Donawho |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Cherrie K. Donawho |
| authorships[3].is_corresponding | False |
| authorships[4].author.id | https://openalex.org/A5073044716 |
| authorships[4].author.orcid | https://orcid.org/0000-0001-8711-7292 |
| authorships[4].author.display_name | Enrico L. DiGiammarino |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Enrico L. DiGiammarino |
| authorships[4].is_corresponding | False |
| authorships[5].author.id | https://openalex.org/A5015353243 |
| authorships[5].author.orcid | https://orcid.org/0009-0000-4198-7559 |
| authorships[5].author.display_name | Sanjay C. Panchal |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Sanjay C. Panchal |
| authorships[5].is_corresponding | False |
| authorships[6].author.id | https://openalex.org/A5104111163 |
| authorships[6].author.orcid | |
| authorships[6].author.display_name | Vivek C. Abraham |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | Vivek C. Abraham |
| authorships[6].is_corresponding | False |
| authorships[7].author.id | https://openalex.org/A5002531603 |
| authorships[7].author.orcid | |
| authorships[7].author.display_name | Mikkel A. Algire |
| authorships[7].author_position | middle |
| authorships[7].raw_author_name | Mikkel A. Algire |
| authorships[7].is_corresponding | False |
| authorships[8].author.id | https://openalex.org/A5100659473 |
| authorships[8].author.orcid | https://orcid.org/0000-0003-4119-3702 |
| authorships[8].author.display_name | Yan Shi |
| authorships[8].author_position | middle |
| authorships[8].raw_author_name | Yan Shi |
| authorships[8].is_corresponding | False |
| authorships[9].author.id | https://openalex.org/A5091311512 |
| authorships[9].author.orcid | |
| authorships[9].author.display_name | Amanda M. Olson |
| authorships[9].author_position | middle |
| authorships[9].raw_author_name | Amanda M. Olson |
| authorships[9].is_corresponding | False |
| authorships[10].author.id | https://openalex.org/A5066317274 |
| authorships[10].author.orcid | |
| authorships[10].author.display_name | Eric F. Johnson |
| authorships[10].author_position | middle |
| authorships[10].raw_author_name | Eric F. Johnson |
| authorships[10].is_corresponding | False |
| authorships[11].author.id | https://openalex.org/A5044583695 |
| authorships[11].author.orcid | https://orcid.org/0000-0002-7977-9031 |
| authorships[11].author.display_name | Julie L. Wilsbacher |
| authorships[11].author_position | middle |
| authorships[11].raw_author_name | Julie L. Wilsbacher |
| authorships[11].is_corresponding | False |
| authorships[12].author.id | https://openalex.org/A5059093147 |
| authorships[12].author.orcid | |
| authorships[12].author.display_name | David Maag |
| authorships[12].author_position | last |
| authorships[12].raw_author_name | David Maag |
| authorships[12].is_corresponding | False |
| has_content.pdf | True |
| has_content.grobid_xml | True |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://aacr.figshare.com/articles/journal_contribution/Supplementary_Figure_2_from_PARP1_Trapping_by_PARP_Inhibitors_Drives_Cytotoxicity_in_Both_Cancer_Cells_and_Healthy_Bone_Marrow/22514782/1/files/39977281.pdf |
| open_access.oa_status | gold |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Supplementary Figure 2 from PARP1 Trapping by PARP Inhibitors Drives Cytotoxicity in Both Cancer Cells and Healthy Bone Marrow |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T11914 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 0.9969000220298767 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2730 |
| primary_topic.subfield.display_name | Oncology |
| primary_topic.display_name | PARP inhibition in cancer therapy |
| related_works | https://openalex.org/W4206015794, https://openalex.org/W4388007145, https://openalex.org/W4387382776, https://openalex.org/W2082618949, https://openalex.org/W3181862256, https://openalex.org/W591723036, https://openalex.org/W26640823, https://openalex.org/W2562451460, https://openalex.org/W2604684522, https://openalex.org/W3081569548 |
| cited_by_count | 0 |
| locations_count | 1 |
| best_oa_location.id | doi:10.1158/1541-7786.22514782 |
| best_oa_location.is_oa | True |
| best_oa_location.source | |
| best_oa_location.license | cc-by |
| best_oa_location.pdf_url | https://aacr.figshare.com/articles/journal_contribution/Supplementary_Figure_2_from_PARP1_Trapping_by_PARP_Inhibitors_Drives_Cytotoxicity_in_Both_Cancer_Cells_and_Healthy_Bone_Marrow/22514782/1/files/39977281.pdf |
| best_oa_location.version | acceptedVersion |
| best_oa_location.raw_type | posted-content |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | False |
| best_oa_location.raw_source_name | |
| best_oa_location.landing_page_url | https://doi.org/10.1158/1541-7786.22514782 |
| primary_location.id | doi:10.1158/1541-7786.22514782 |
| primary_location.is_oa | True |
| primary_location.source | |
| primary_location.license | cc-by |
| primary_location.pdf_url | https://aacr.figshare.com/articles/journal_contribution/Supplementary_Figure_2_from_PARP1_Trapping_by_PARP_Inhibitors_Drives_Cytotoxicity_in_Both_Cancer_Cells_and_Healthy_Bone_Marrow/22514782/1/files/39977281.pdf |
| primary_location.version | acceptedVersion |
| primary_location.raw_type | posted-content |
| primary_location.license_id | https://openalex.org/licenses/cc-by |
| primary_location.is_accepted | True |
| primary_location.is_published | False |
| primary_location.raw_source_name | |
| primary_location.landing_page_url | https://doi.org/10.1158/1541-7786.22514782 |
| publication_date | 2023-04-03 |
| publication_year | 2023 |
| referenced_works_count | 0 |
| abstract_inverted_index.by | 8 |
| abstract_inverted_index.of | 1 |
| abstract_inverted_index.and | 3 |
| abstract_inverted_index.Assay | 11 |
| abstract_inverted_index.PARP1 | 2 |
| abstract_inverted_index.other | 4 |
| abstract_inverted_index.histone | 5 |
| abstract_inverted_index.Ligation | 10 |
| abstract_inverted_index.detected | 7 |
| abstract_inverted_index.proteins | 6 |
| abstract_inverted_index.Proximity | 9 |
| abstract_inverted_index.(PLA).</p> | 12 |
| abstract_inverted_index.<p>Association | 0 |
| cited_by_percentile_year | |
| countries_distinct_count | 0 |
| institutions_distinct_count | 13 |
| citation_normalized_percentile.value | 0.26277827 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |